Evidence map›Paper›PMID 37681895›Full record

ArticleCells2023

Medium-Chain Fatty Acids Rescue Motor Function and Neuromuscular Junction Degeneration in a

Ella Dunn, Joern R Steinert, Aelfwin Stone, Virender Sahota, Robin S B Williams, Stuart Snowden, Hrvoje Augustin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Decoding Nucleotide Repeat Expansion Diseases: Novel Insights fromInternational journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ella DunnCentre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.
Joern R SteinertFaculty of Medicine & Health Sciences, Queen's Medical Centre, Nottingham NG7 2UH, UK.ORCID 0000-0003-1640-0845
Aelfwin StoneFaculty of Medicine & Health Sciences, Queen's Medical Centre, Nottingham NG7 2UH, UK.
Virender SahotaCentre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.
Robin S B WilliamsCentre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.ORCID 0000-0002-9826-6020
Stuart SnowdenCentre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.
Hrvoje AugustinCentre for Biomedical Sciences, Department of Biological Sciences, Royal Holloway University of London, Egham, Surrey TW20 OEX, UK.
Royal Holloway University of London · GBQueen's Medical Centre · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is an adult-onset neurodegenerative disease characterised by progressive degeneration of the motor neurones. An expanded

Indexed as

Amyotrophic Lateral SclerosisFrontotemporal DementiaNeurodegenerative DiseasesAnimalsDrosophilaDrosophila melanogasterFatty AcidsLarvaNeuromuscular JunctionFatty Acids4-MOAALSDrosophilaglutamateMCFAmotor functionNANMJ

Identifiers

PMID37681895
PMCPMC10486503
OpenAlexW4386250991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.